Validity of a Smartphone App to Objectively Monitor Performance Outcomes in Degenerative Cervical Myelopathy: Preliminary Findings From a Longitudinal Observational Study

Alvaro Yanez Touzet   ^{1, 2} , BSc (Hons) ;   Tatiana Houhou   ^{3 *} , BSc ;   Zerina Rahic   ^{3 *} , BSc ;   Ilya Laufer   ⁴ , MD ;   Konstantinos Margetis   ⁵ , MD, PhD ;   Allan R Martin   ⁶ , MD, PhD ;   Nicolas Dea   ⁷ , MD, MSc ;   Zoher Ghogawala   ⁸ , MD ;   Misha Kapushesky   ² , BA, PhD ;   Mark R N Kotter   ^{2, 9, 10} , MD, MPhil, PhD ;   Benjamin M Davies   ^{2, 11} , BSc, MBChB (Hons), MPhil, DPhil ;   MoveMed   ^{12 *}

¹ School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom

² MoveMed Ltd, Cambridge, United Kingdom

³ Division of Science, New York University Abu Dhabi, Abu Dhabi, United Arab Emirates

⁴ NYU Langone Health, New York, NY, United States

⁵ Icahn School of Medicine at Mount Sinai, New York, NY, United States

⁶ Department of Neurological Surgery, University of California, Davis, Davis, CA, United States

⁷ Department of Surgery, University of British Columbia, Vancouver, BC, Canada

⁸ Lahey Hospital and Medical Center, Burlington, MA, United States

⁹ Department of Clinical Neurosurgery, University of Cambridge, Cambridge, United Kingdom

¹⁰ Department of Clinical Neurosciences, Ann McLaren Laboratory of Regenerative Medicine, Cambridge, United Kingdom

¹¹ Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom

¹² See Acknowledgements, Cambridge, United Kingdom

*these authors contributed equally